Company chart and information is provided by TradingView based on 15-minute-delayed data.
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
| Website: | www.glaukos.com |
| Email: | clewis@glaukos.com |
| Main Phone: | +1 949 367-9600 |
| Address: | 229 Avenida Fabricante |
| Address 2: | Suite 103 |
| State: | CA |
| City / Town: | San Clemente |
| Country: | US |
| Postal Code: | 92672 |
| Exchange: | NYE |
| CEO: | Thomas W. Burns |
| Employees: | 653 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
